DCF — POST ACUTE MEDICAL OF NEW BRAUNFELS
Enterprise Value: $17.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$17.1M
Enterprise Value
$4.5M
PV of Cash Flows
$12.6M
PV of Terminal Value
$20.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $21.7M | $2.2M | 10.0% | $0.9M | $0.8M |
| Year 2 | $22.4M | $2.5M | 11.0% | $1.1M | $0.9M |
| Year 3 | $23.1M | $2.8M | 12.0% | $1.3M | $1.0M |
| Year 4 | $23.8M | $3.0M | 13.0% | $1.4M | $1.0M |
| Year 5 | $24.5M | $3.2M | 13.0% | $1.5M | $0.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $17.1M. Terminal value accounts for 74% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$21.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.09646748868297401
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5